Evidose

Wilmington, United States Founded: 2023 • Age: 3 yrs
High-quality scientific data is provided for supplement and pharma sectors.
Request Access

About Evidose

Evidose is a company based in Wilmington (United States) founded in 2023 by Anna Litwinska and Kacper Zambrzycki.. Evidose has raised $500 thousand across 1 funding round from investors including Inovo Venture Partners and 500 Global. Evidose offers products and services including Clinical Trial Platform and Trial Effectiveness Services. Evidose operates in a competitive market with competitors including Nutrino, Edamam, MenuTrinfo, ESHA Research and Nutrition Integrated, among others.

  • Headquarter Wilmington, United States
  • Founders Anna Litwinska, Kacper Zambrzycki
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Evidose Inc.
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $500 K (USD)

    in 1 rounds

  • Latest Funding Round
    $500 K (USD), Seed

    Nov 29, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Evidose

Evidose offers a comprehensive portfolio of products and services, including Clinical Trial Platform and Trial Effectiveness Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides tools to optimize clinical trial processes and results

Offers expert support for improving clinical research efficiency

Funding Insights of Evidose

Evidose has successfully raised a total of $500K through 1 strategic funding round. The most recent funding activity was a Seed round of $500 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $500,000
  • First Round

    (29 Nov 2023)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Seed - Evidose Valuation Inovo Venture Partners , 500 Global
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Evidose

Evidose has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Inovo Venture Partners and 500 Global. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Tech-focused venture capital firm
Founded Year Domain Location
Venture capital and acceleration are provided to tech startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Evidose

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Evidose

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Evidose Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Evidose

Evidose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nutrino, Edamam, MenuTrinfo, ESHA Research and Nutrition Integrated, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of nutrition-based data services and analytics technology
domain founded_year HQ Location
Provider of a cloud-based semantic technology platform that aggregates recipes
domain founded_year HQ Location
Provides accredited food allergy training, certifications, and nutritional analysis services.
domain founded_year HQ Location
Provides software for food compliance, formulation, and traceability solutions.
domain founded_year HQ Location
Provides data-driven insights and solutions for active nutrition businesses.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Evidose

Frequently Asked Questions about Evidose

When was Evidose founded?

Evidose was founded in 2023.

Where is Evidose located?

Evidose is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

Who is the current CEO of Evidose?

Anna Litwinska is the current CEO of Evidose. They have also founded this company.

Is Evidose a funded company?

Evidose is a funded company, having raised a total of $500K across 1 funding round to date. The company's 1st funding round was a Seed of $500K, raised on Nov 29, 2023.

What does Evidose do?

Evidose was founded in 2023 and is based in Wilmington, United States. A platform is maintained to deliver scientifically robust data tailored for the supplement and pharmaceutical industries. Data-driven insights are supplied to support the wellness sector, where transparency and analytical rigor are applied to supplements and nutraceuticals. The company is co-led by Anna Litwinska as CEO and Kacper Zambrzycki as COO.

Who are the top competitors of Evidose?

Evidose's top competitors include Nutrino, Edamam and MenuTrinfo.

What products or services does Evidose offer?

Evidose offers Clinical Trial Platform and Trial Effectiveness Services.

Who are Evidose's investors?

Evidose has 2 investors. Key investors include Inovo Venture Partners, and 500 Global.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available